Offering self-sampling devices to increase cervical cancer screening in underscreened women
Efficacy of Offering a Self-sampling Device by the General Practitioner to Reach Women Underscreened in the Routine Cervical Cancer Screening Program Compared to Sending Reminder Letters by the Screening Organization
NA · University Ghent · NCT05656976
This study tests whether giving women aged 31 to 65 a self-sampling device for cervical cancer screening through their doctor or by mail can help more of them get screened.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 3375 (estimated) |
| Ages | 31 Years to 64 Years |
| Sex | Female |
| Sponsor | University Ghent (other) |
| Locations | 1 site (Ghent) |
| Trial ID | NCT05656976 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of providing a self-sampling device (SSD) to women aged 31 to 65 who have not undergone cervical screening in the past six years. It compares two methods of offering the SSD: through direct interaction with a general practitioner (GP) or by sending it via mail. The study is designed as a randomized control trial with three arms to assess the impact of these interventions on screening rates. It is a collaborative effort involving multiple universities and cancer organizations in Belgium.
Who should consider this trial
Good fit: Ideal candidates are women aged 31 to 64 living in Flanders who have not had a cervical smear in the last six years.
Not a fit: Patients who have had a hysterectomy, are currently pregnant, or have a past diagnosis of cervical cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase cervical cancer screening rates among underscreened women, leading to earlier detection and improved outcomes.
How similar studies have performed: Similar studies have shown promise in increasing screening rates through self-sampling methods, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women between 31-64 years old * living in Flanders * eligible for the Flemish actions with regard to population screening * without a smear registered in the Belgian Cancer Registry in the last 6 years * registered as GMD patient in one of the participating GP practices Exclusion Criteria: * hysterectomy * pregnancy * (past) diagnosis of cervical cancer
Where this trial is running
Ghent
- Ghent University — Ghent, Belgium (RECRUITING)
Study contacts
- Principal investigator: Kaatje Van Roy — University Ghent
- Study coordinator: Sara Willems, prof. dr.
- Email: sara.willems@ugent.be
- Phone: +32 9 332 39 84
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cervical Cancer, Prevention, Screening